• LAST PRICE
    1.0100
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (1.0000%)
  • Bid / Lots
    1.0200/ 10
  • Ask / Lots
    1.0300/ 7
  • Open / Previous Close
    1.0100 / 1.0000
  • Day Range
    Low 1.0100
    High 1.0300
  • 52 Week Range
    Low 0.7324
    High 2.2700
  • Volume
    324,174
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1
TimeVolumeASRT
09:32 ET58501.021
09:39 ET90191.01
09:42 ET5091.015728
09:44 ET73721.0106
09:46 ET50001.0196
09:48 ET19801.015
09:50 ET19801.0194
09:51 ET39441.0198
09:57 ET11001.0154
10:02 ET9001.0198
10:04 ET10001.015
10:06 ET26741.02
10:09 ET31001.01
10:11 ET2291.02
10:13 ET36001.0199
10:18 ET2151.02
10:20 ET1001.015
10:22 ET26891.015
10:26 ET20001.0158
10:27 ET78001.0157
10:33 ET2951.02
10:40 ET2841.0113
10:44 ET10001.01
10:47 ET12001.02
10:51 ET1001.02
10:54 ET3001.0147
10:56 ET108961.025
10:58 ET11231.02
11:02 ET23501.02
11:03 ET54351.025
11:07 ET13961.02
11:09 ET38401.0199
11:12 ET83091.02
11:14 ET1001.0289
11:18 ET107801.0206
11:20 ET2001.02
11:21 ET13241.0207
11:23 ET4001.02
11:25 ET1001.02
11:27 ET7971.02
11:30 ET6121.025
11:32 ET7001.02
11:34 ET9001.02
11:36 ET4001.02
11:38 ET17261.025
11:41 ET51211.0203
11:43 ET72061.0206
11:45 ET14001.025
11:48 ET2001.0295
11:56 ET2501.02
12:03 ET2281.0204
12:14 ET1001.03
12:17 ET18001.0291
12:28 ET5941.021
12:32 ET1001.03
12:42 ET1001.0215
12:44 ET40301.03
12:50 ET9481.0244
12:57 ET6201.02
01:02 ET5001.0207
01:06 ET2001.025
01:09 ET3001.0245
01:11 ET2001.03
01:13 ET5001.03
01:20 ET1781.03
01:22 ET21001.02
01:31 ET11001.03
01:42 ET1001.02
01:47 ET4001.02
01:49 ET30961.0235
01:56 ET17861.02
02:00 ET1001.02
02:02 ET2001.02
02:05 ET1001.02
02:07 ET71431.0289
02:09 ET1001.02
02:12 ET5991.02
02:14 ET2001.03
02:16 ET2001.02
02:18 ET3001.02
02:21 ET1001.02
02:25 ET1001.02
02:27 ET2001.02
02:30 ET4001.025
02:32 ET1001.03
02:34 ET1001.025
02:39 ET2421.0299
02:43 ET1001.0219
02:45 ET5451.02
02:48 ET11001.025
02:50 ET3001.02
02:52 ET6001.02
02:54 ET11991.02
02:56 ET11001.02
02:57 ET20601.02
02:59 ET4001.02
03:01 ET5321.02
03:03 ET18871.025
03:06 ET7001.02
03:08 ET17001.02
03:10 ET5001.02
03:12 ET2001.025
03:17 ET2001.02
03:28 ET56501.025
03:30 ET104101.03
03:33 ET37001.02
03:37 ET6001.02
03:39 ET161921.015
03:42 ET30001.0186
03:44 ET56341.02
03:46 ET46481.0201
03:48 ET202001.015
03:50 ET44001.015
03:51 ET150091.01
03:53 ET4881.015
03:57 ET44001.02
04:00 ET488231.01
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesASRT
Assertio Holdings Inc
95.3M
-0.2x
---
United StatesSCYX
SCYNEXIS Inc
50.0M
-1.8x
---
United StatesAOBI
American Oriental Bioengineering Inc
30.0
0.0x
---
United StatesBVNRY
Bavarian Nordic A/S
2.3B
22.5x
---
United StatesLFCR
Lifecore Biomedical Inc
236.1M
173.0x
+27.97%
United StatesNAII
Natural Alternatives International Inc
28.1M
-3.7x
---
As of 2024-11-07

Company Information

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Contact Information

Headquarters
100 S. Saunders Road, Suite 300LAKE FOREST, IL, United States 60045
Phone
224-419-7106
Fax
302-636-5454

Executives

Chief Executive Officer, Director
Brendan O'Grady
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Ajay Patel
Senior Vice President, General Counsel, Executive Officer
Sam Schlessinger
Senior Vice President and Chief Commercial Officer
Paul Schwichtenberg
Independent Director
Sravan Emany

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$95.3M
Revenue (TTM)
$132.2M
Shares Outstanding
95.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.83
EPS
$-4.11
Book Value
$1.46
P/E Ratio
-0.2x
Price/Sales (TTM)
0.7
Price/Cash Flow (TTM)
---
Operating Margin
-203.16%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.